APA (7th ed.) Citation

Pike, K. G., Barlaam, B., Cadogan, E., Campbell, A., Chen, Y., Colclough, N., . . . Al-Huniti, N. (2018). The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one). Journal of medicinal chemistry, 61(9), 3823-3841. https://doi.org/10.1021/acs.jmedchem.7b01896

Chicago Style (17th ed.) Citation

Pike, Kurt G., et al. "The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)." Journal of Medicinal Chemistry 61, no. 9 (2018): 3823-3841. https://doi.org/10.1021/acs.jmedchem.7b01896.

MLA (9th ed.) Citation

Pike, Kurt G., et al. "The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one)." Journal of Medicinal Chemistry, vol. 61, no. 9, 2018, pp. 3823-3841, https://doi.org/10.1021/acs.jmedchem.7b01896.